Overview

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether asimadoline is safe and effective at treating D-IBS.
Phase:
Phase 3
Details
Lead Sponsor:
Tioga Pharmaceuticals
Collaborator:
RTI Health Solutions